Skip Navigation

Private sector not giving antimalarials to the people they should

A study in Tanzanian drug shops showed that most malaria patients did not receive an antimalarial and most people who obtained one didnít in fact have malaria.

Malaria research publications

Browse through more than 50 journal articles published by ACT Consortium investigators on the access, targeting, safety and quality of antimalarials.

Our work

We do research to improve access and targeting, and assess the quality and safety of artemisinin-based combination treatment (ACT), the WHO recommended first-line treatment for malaria.

Videos of our research projects

Our revamped website includes videos with ACT Consortium investigators talking about their studies on the access, targeting, quality and safety of ACT drugs.

View all ACT Consortium news

The ACT Consortium is an international research collaboration formed in November 2007 to answer key questions on malaria drug delivery in Africa and Asia.  

Our goal is to develop and evaluate delivery mechanisms to improve ACT access, targeting, safety and quality. 

The ACT Consortium is funded by the Bill & Melinda Gates Foundation and has partners throughout Africa, Asia, Europe and the United States.  It is coordinated through the London School of Hygiene & Tropical Medicine.